Bladder cancer: open trials in Chile

• NCT06330064

  A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  Trial Treatment · Phase 1/2 · Daiichi Sankyo

  Biocenter, Concepción · Ic La Serena Research, La Serena · Clinica Redsalud Vitacura, Santiago · Centro Del Cancer UC, Santiago · James Lind Centro De Investigacion Del Cancer, Temuco

  Registry updated 2026-10-26

• NCT07232602

  KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  Fundación Arturo López Pérez ( Site 5151), Santiago

  Registry updated 2026-10-02

• NCT06833073

  A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

  Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC

  Bradford Hill Norte ( Site 0503), Antofagasta · Fundación Arturo López Pérez ( Site 0500), Santiago · Pontificia Universidad Catolica de Chile ( Site 0502), Santiago · Bradfordhill ( Site 0501), Santiago · Oncocentro Valdivia ( Site 0507), Valdivia · ONCOCENTRO APYS ( Site 0505), Viña del Mar

  Registry updated 2026-10-01

• NCT05562830

  A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  FALP-UIDO ( Site 1151), Santiago · Bradford Hill ( Site 1155), Santiago

  Registry updated 2026-09-28

• NCT04879329

  A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

  Trial Treatment · Phase 2 · Seagen, a wholly owned subsidiary of Pfizer

  Centro de Estudios Clínicos IC La Serena Research, La Serena · Oncovida SA, Providencia · Pontificia Universidad Catolica de Chile, Santiago

  Registry updated 2026-07-22

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error